PE20020755A1 - Procedimiento para la preparacion de un anticolinergico - Google Patents

Procedimiento para la preparacion de un anticolinergico

Info

Publication number
PE20020755A1
PE20020755A1 PE2001001285A PE2001001285A PE20020755A1 PE 20020755 A1 PE20020755 A1 PE 20020755A1 PE 2001001285 A PE2001001285 A PE 2001001285A PE 2001001285 A PE2001001285 A PE 2001001285A PE 20020755 A1 PE20020755 A1 PE 20020755A1
Authority
PE
Peru
Prior art keywords
ester
thenyl
glycolic acid
bromide
procedure
Prior art date
Application number
PE2001001285A
Other languages
English (en)
Spanish (es)
Inventor
Rolf Banholzer
Manfred Graulich
Andreas Mathes
Peter Specht
Wolfgang Broeder
Helmut Meissner
Sven Luettke
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7668836&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20020755(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PE20020755A1 publication Critical patent/PE20020755A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
PE2001001285A 2000-12-22 2001-12-20 Procedimiento para la preparacion de un anticolinergico PE20020755A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10064816A DE10064816A1 (de) 2000-12-22 2000-12-22 Verfahren zur Herstellung eines Anticholinergikums

Publications (1)

Publication Number Publication Date
PE20020755A1 true PE20020755A1 (es) 2002-09-24

Family

ID=7668836

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001001285A PE20020755A1 (es) 2000-12-22 2001-12-20 Procedimiento para la preparacion de un anticolinergico

Country Status (41)

Country Link
US (1) US6486321B2 (cs)
EP (2) EP1426373B1 (cs)
JP (1) JP4198991B2 (cs)
KR (1) KR100853109B1 (cs)
CN (2) CN1244581C (cs)
AR (1) AR033599A1 (cs)
AT (2) ATE266661T1 (cs)
AU (1) AU2002229650B2 (cs)
BG (1) BG66373B1 (cs)
BR (1) BRPI0116444B8 (cs)
CA (1) CA2433518C (cs)
CY (1) CY1105210T1 (cs)
CZ (1) CZ294958B6 (cs)
DE (3) DE10064816A1 (cs)
DK (2) DK1345936T3 (cs)
EA (1) EA005533B1 (cs)
EC (1) ECSP034652A (cs)
EE (1) EE04495B1 (cs)
EG (1) EG23914A (cs)
ES (2) ES2221658T3 (cs)
HR (1) HRP20030502B1 (cs)
HU (1) HU230320B1 (cs)
IL (2) IL156351A0 (cs)
ME (1) MEP40608A (cs)
MX (1) MXPA03005426A (cs)
MY (1) MY129525A (cs)
NO (1) NO327739B1 (cs)
NZ (1) NZ527066A (cs)
PE (1) PE20020755A1 (cs)
PL (1) PL202478B1 (cs)
PT (2) PT1345936E (cs)
RS (1) RS50271B (cs)
SA (1) SA01220589B1 (cs)
SI (1) SI1345936T1 (cs)
SK (1) SK287318B6 (cs)
TR (1) TR200401127T4 (cs)
TW (1) TWI234564B (cs)
UA (1) UA74409C2 (cs)
UY (1) UY27079A1 (cs)
WO (1) WO2002051840A1 (cs)
ZA (1) ZA200304707B (cs)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12522A (en) * 2000-10-12 2006-05-30 Boehringer Ingelheim Pharma Novel tiotropium-containing inhalation powder.
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US6852728B2 (en) 2000-10-14 2005-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
US20030013675A1 (en) * 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
CA2450961C (en) * 2001-06-22 2010-03-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6608055B2 (en) 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US6790856B2 (en) * 2002-01-31 2004-09-14 Boehringer Ingelheim Pharma Kg Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
US7405224B2 (en) * 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US7311894B2 (en) * 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
JP2005526103A (ja) * 2002-04-04 2005-09-02 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 吸入に適した粉末製剤
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
NZ547276A (en) * 2003-11-03 2009-08-28 Boehringer Ingelheim Int Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
JP5165245B2 (ja) * 2003-11-03 2013-03-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規なチオトロピウム塩、その製造方法及びチオトロピウム塩を含有する医薬組成物
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
NZ563596A (en) 2005-05-02 2011-01-28 Boehringer Ingelheim Int Crystalline form of tiotropium bromide anhydrate
AU2006243239A1 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide
CN101227905A (zh) * 2005-06-15 2008-07-23 贝林格尔·英格海姆国际有限公司 制备噻托铵盐的方法、噻托铵盐及其药物组合物
DE102005035112A1 (de) * 2005-07-27 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
CN1316245C (zh) * 2005-07-28 2007-05-16 山东齐都药业有限公司 托烷司琼合成中残留中间体托品醇的检测方法
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
DE102005059602A1 (de) 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mikronisierung
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
MX2007009988A (es) * 2005-12-19 2008-02-22 Sicor Inc Formas novedosas de bromuro de tiotropio y procesos para su preparacion.
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
RU2453547C2 (ru) * 2005-12-19 2012-06-20 Сикор Инк. Новые формы тиотропия бромида и способы их получения
CA2620142A1 (en) * 2005-12-19 2007-07-05 Sicor Inc. Pure and stable tiotropium bromide
CN100410254C (zh) * 2006-03-07 2008-08-13 南昌弘益科技有限公司 噻托溴铵无水物制备方法
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
EP1882691A1 (en) * 2006-07-26 2008-01-30 CHIESI FARMACEUTICI S.p.A. Quinuclidine derivatives as M3 antagonists
EP1950196A1 (de) * 2007-01-29 2008-07-30 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Ammoniumhexafluorophosphaten
EP2036898A2 (de) * 2007-09-13 2009-03-18 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von 1,3-Dioxolan-2Onen sowie von Carbonsäureestern durch Transacylierung unter Basischen Reaktionsbedingungen
PL2240477T3 (pl) * 2008-01-10 2015-03-31 Generics Uk Ltd Nowy sposób wytwarzania estrów skopiny
WO2011015884A1 (en) * 2009-08-07 2011-02-10 Generics [Uk] Limited Process to prepare scopine esters
IN2012DN00968A (cs) 2009-08-07 2015-04-10 Generics Uk Ltd
CN101768158B (zh) * 2010-01-04 2013-05-29 南昌弘益科技有限公司 噻托溴铵无水物及其制备方法
CN101863885B (zh) * 2010-06-03 2012-05-30 南京金丹呈医药技术有限公司 一种噻托溴铵的制备方法
TR201007108A2 (tr) * 2010-08-25 2012-03-21 B�Lg�� Mahmut Yeni tiotropyum bromür kristali ve üretim yöntemi.@
ITRM20110508A1 (it) 2011-09-27 2013-03-28 Lusochimica Spa Processo per la preparazione degli esteri della scopina.
HUE034540T2 (en) * 2011-12-22 2018-02-28 Cerbios Pharma Sa Continuous process for the alkylation of cyclic tertiary amines
PT106142B (pt) 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A Processo para a preparação de brometo de tiotrópio
CZ305012B6 (cs) * 2012-03-30 2015-03-25 Zentiva, K.S. Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu
KR20150135328A (ko) 2013-04-01 2015-12-02 풀매트릭스 인코퍼레이티드 티오트로피움 건조 분말
WO2018055642A1 (en) * 2016-09-23 2018-03-29 Gbr Laboratories Pvt. Ltd. A process for preparing tiotropium bromide and intermediates thereof
WO2019129801A1 (en) 2017-12-28 2019-07-04 Linnea S.A. Process for the purification of methyl-2,2-dithienylglycolate
CN113264929B (zh) * 2021-05-02 2023-10-10 润生药业有限公司 一种噻托溴铵的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US5770738A (en) * 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions

Also Published As

Publication number Publication date
JP4198991B2 (ja) 2008-12-17
BR0116444A (pt) 2003-12-23
CN1840529A (zh) 2006-10-04
IL156351A0 (en) 2004-01-04
EE200300309A (et) 2003-10-15
DE50110835D1 (de) 2006-10-05
DE50102299D1 (de) 2004-06-17
ES2221658T3 (es) 2005-01-01
NO327739B1 (no) 2009-09-14
KR20030062439A (ko) 2003-07-25
CN1244581C (zh) 2006-03-08
DK1345936T3 (da) 2004-07-19
CN1481383A (zh) 2004-03-10
TWI234564B (en) 2005-06-21
HRP20030502B1 (en) 2011-09-30
EG23914A (en) 2007-12-30
EP1426373B1 (de) 2006-08-23
EP1345936B1 (de) 2004-05-12
BG66373B1 (bg) 2013-10-31
KR100853109B1 (ko) 2008-08-21
SK9352003A3 (en) 2003-10-07
NO20032827D0 (no) 2003-06-20
BRPI0116444B1 (pt) 2015-09-01
CN100393719C (zh) 2008-06-11
ATE266661T1 (de) 2004-05-15
HRP20030502A2 (en) 2005-04-30
EE04495B1 (et) 2005-06-15
CA2433518A1 (en) 2002-07-04
EA200300666A1 (ru) 2003-12-25
PT1345936E (pt) 2004-09-30
NO20032827L (no) 2003-06-20
SK287318B6 (sk) 2010-07-07
ES2271722T3 (es) 2007-04-16
ZA200304707B (en) 2004-04-20
SA01220589B1 (ar) 2006-10-31
CZ294958B6 (cs) 2005-04-13
AR033599A1 (es) 2003-12-26
HK1096683A1 (zh) 2007-06-08
JP2004525099A (ja) 2004-08-19
BG107910A (bg) 2004-02-27
NZ527066A (en) 2004-12-24
TR200401127T4 (tr) 2004-07-21
YU50903A (sh) 2006-05-25
ATE337314T1 (de) 2006-09-15
MXPA03005426A (es) 2005-04-20
US6486321B2 (en) 2002-11-26
WO2002051840A1 (de) 2002-07-04
UA74409C2 (uk) 2005-12-15
RS50271B (sr) 2009-07-15
PT1426373E (pt) 2006-11-30
DE10064816A1 (de) 2002-06-27
DK1426373T3 (da) 2006-12-18
US20020133010A1 (en) 2002-09-19
UY27079A1 (es) 2002-07-31
AU2002229650B2 (en) 2006-12-21
MEP40608A (en) 2011-02-10
EA005533B1 (ru) 2005-04-28
PL202478B1 (pl) 2009-06-30
EP1426373A1 (de) 2004-06-09
EP1345936A1 (de) 2003-09-24
HUP0301457A3 (en) 2006-05-29
PL361837A1 (en) 2004-10-04
CA2433518C (en) 2007-03-20
CZ20031685A3 (cs) 2003-10-15
MY129525A (en) 2007-04-30
HUP0301457A2 (hu) 2003-10-28
IL156351A (en) 2011-09-27
CY1105210T1 (el) 2010-03-03
HK1060570A1 (en) 2004-08-13
HU230320B1 (hu) 2016-01-28
SI1345936T1 (sl) 2004-08-31
BRPI0116444B8 (pt) 2021-05-25
ECSP034652A (es) 2003-07-25

Similar Documents

Publication Publication Date Title
PE20020755A1 (es) Procedimiento para la preparacion de un anticolinergico
ES2229538T3 (es) Derivados de pleuromutilina como agentes antimicrobianos.
GT200100141A (es) Esteres oxigenados de acidos 4-yodo fenilamino benzhidroxamicos.
MX9303441A (es) Procedimiento para la preparacion de acido clavulanico.
ES2150941T3 (es) Aminas biciclicas-heterociclicas eficaces farmaceuticamente.
AR083071A1 (es) Uso de analogos de nucleosidos y nucleotidos para tratar infecciones virales por paramixovirus y/o ortomixovirus, compuestos relacionados y composiciones farmaceuticas que los contienen
DK1401837T3 (da) Purinderivater som A2B-adenosinreceptorantagonister
PE20120997A1 (es) Compuestos policiclicos como antagonistas del receptor de acido lisofosfatidico
PE20091583A1 (es) Solucion para infusion de dihidropteridinonas estabilizada para el almacenamiento
AR019478A1 (es) Ligandos derivados de piperidina de alta afinidad para el receptor de nociceptina orl-1, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos.
UY25887A1 (es) Derivados bicíclicos sustituidos útiles como agentes contra el cáncer
AR026424A1 (es) Soluciones que contienen epinastina
ES2038701T3 (es) Un ester de acido lactico-acido graso.
AR035511A1 (es) Procedimiento para preparar una cefalosporina e intermediarios de sintesis
ES2242022T3 (es) Procedimiento de sintesis tecnica para la preparacion de tropenol.
ECSP003680A (es) Proceso para derivados del acido fenilacetico
EA200200700A1 (ru) Замещенные гомопиперидильные аналоги бензимидазола как фундальные релаксанты
ATE32462T1 (de) Triazolopyrimidinderivate, verfahren zu ihrer herstellung und ihre therapeutische anwendung als kardiotonika.
ES2211954T3 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
PE20030092A1 (es) Formulacion de una solucion de inhalacion con una sal de tiotropio
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
NO156566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridiner.
ES2202090T3 (es) Enantiomeros de mercaptolactonas y procedimiento para su sintesis.
HRP20040889B1 (hr) Hfa suspenzijske formulacije koje sadrže antiholinergik
PE20011012A1 (es) Benzoxa y benzotiazoles como inhibidores de sulfatasa de esteroide

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed